DHL’s Automated Healthcare Hub Signals the Future of UK Life Sciences Supply Chains
DHL Supply Chain is investing in a new automated healthcare logistics hub at Infinity Park Derby, combining shared-user warehousing, multi-temperature capabilities and sustainability-led design. The facility reflects how healthcare supply chains are evolving to meet growing demand for pharmaceuticals, medical devices and consumer health products through greater resilience, scalability and automation.
Heidi : Moving AI in General Practice from Burden to Genuine Digital Relief
Dr Hannah Allen, practising GP and Chief Medical Officer at Heidi – a digital artificial intelligence (AI) care partner – provides key insights into what safety-first AI in healthcare looks like in practice.
Haleon Expands Rural Health Access in India with £175 Million Manufacturing and Distribution Investment
New Haleon manufacturing facility and expanded community outreach aim to improve oral health access for more than 300 million additional consumers.
NHS England Embraces AI With the Roll-out of Microsoft 365 Copilot
Microsoft 365 Copilot is set to support 500,000 clinicians and support staff as NHS England accelerates artificial intelligence adoption across healthcare services.
Google Breaks Ground on Swedish Data Centre
Google is breaking ground in Sweden with the construction of a cutting-edge data centre in Horndal, designed not only to enhance its digital services but also to foster community growth and sustainable practices through significant investments and job creation.
Houlihan Lokey : Why the Next Decade of MedTech Belongs to Infrastructure
Paul Tomasic, Managing Director and Head of European Healthcare at Houlihan Lokey, outlines why the sector’s financial prize has shifted from hardware to the underlying digital and physical plumbing of healthcare.
HSBC Innovation Banking Life Sciences’ UK & Europe
Following the release of HSBC Innovation Banking Life Sciences’ UK & Europe: Life Sciences & Healthcare Venture Financing Report for FY25, we sit down with Paula Burke, Director, HealthTech and Medical Devices, and Dominick Kennerson, Director, Business Development, Life Sciences and Healthcare.
Medicines for Malaria Venture : Ending Malaria, Rewriting the Future
Medicines for Malaria Venture is continuing to innovate its R&D pipeline, collaborate with stakeholders, and refine its product development partnership model. Dr Martin Fitchet, CEO, tells us more.
Zipline Rwanda : Autonomous Delivery Across Rwanda
Rwanda is to become the first country in the world with nationwide autonomous delivery, including Africa’s first urban drone delivery network. We learn about this historic expansion agreement with Pierre Kayitana, Country Director of Zipline Rwanda.
Elemind : Sleep On Demand
Elemind is pioneering read-write neurotechnology – the first wearable that can actively improve health in real time, not just measure it. Meredith Perry, co-Founder and CEO, tells us more about redefining what’s possible in neurotechnology and sleep science.
Novo Nordisk and Cellular Intelligence Advance Parkinson’s Therapy
Cellular Intelligence has acquired Novo Nordisk’s clinical-stage Parkinson’s cell therapy programme, combining AI-native manufacturing capabilities with regenerative medicine expertise to accelerate development, scalability, and global commercialisation efforts.
Eli Lilly Expands North America Indiana Manufacturing Investment with Genetic Medicine Facility
Eli Lilly and Company is expanding its domestic pharmaceutical manufacturing footprint with an additional $4.5 billion investment across its Lebanon, Indiana, production sites, while also opening its first dedicated genetic medicine manufacturing facility.
